These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 10463521)

  • 1. Factors contributing to trends in prescription drug expenditures.
    Suh DC; Lacy CR; Barone JA; Moylan D; Kostis JB
    Clin Ther; 1999 Jul; 21(7):1241-53. PubMed ID: 10463521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in prescription drug expenditures by Medicaid enrollees.
    Banthin JS; Miller GE
    Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in the cost of antidepressants across state Medicaid programs.
    Kelton CM; Rebelein RP; Heaton PC; Ferrand Y; Guo JJ
    J Ment Health Policy Econ; 2008 Mar; 11(1):33-47. PubMed ID: 18424875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective assessment of Medicaid step-therapy prior authorization policy for atypical antipsychotic medications.
    Farley JF; Cline RR; Schommer JC; Hadsall RS; Nyman JA
    Clin Ther; 2008 Aug; 30(8):1524-39; discussion 1506-7. PubMed ID: 18803994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in health care expenditures, utilization, and health status among US adults with spine problems, 1997-2006.
    Martin BI; Turner JA; Mirza SK; Lee MJ; Comstock BA; Deyo RA
    Spine (Phila Pa 1976); 2009 Sep; 34(19):2077-84. PubMed ID: 19675510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization, spending, and price trends for benzodiazepines in the US Medicaid program: 1991-2009.
    Gorevski E; Bian B; Kelton CM; Martin Boone JE; Guo JJ
    Ann Pharmacother; 2012 Apr; 46(4):503-12. PubMed ID: 22454448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National health spending in 2005: the slowdown continues.
    Catlin A; Cowan C; Heffler S; Washington B;
    Health Aff (Millwood); 2007; 26(1):142-53. PubMed ID: 17211023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicaid prescription drug utilization and expenditures following Part D.
    Farley JF; Dusetzina SB
    J Health Care Poor Underserved; 2010 May; 21(2):715-28. PubMed ID: 20453368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost effect of newer medication adoption in an older Medicaid cohort.
    Shireman TI; Rigler SK; Jachna CM; Griebling TL; Eng ML
    J Am Geriatr Soc; 2005 Aug; 53(8):1366-73. PubMed ID: 16078963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid expenditures and utilization in the Medicaid system.
    Brixner DI; Oderda GM; Roland CL; Rublee DA
    J Pain Palliat Care Pharmacother; 2006; 20(1):5-13. PubMed ID: 16687350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods for estimating and comparing VA outpatient drug benefits with the private sector.
    Render ML; Nowak J; Hammond EK; Roselle G
    Med Care; 2003 Jun; 41(6 Suppl):II61-9. PubMed ID: 12773828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cluster analysis of state Medicaid prescription drug benefit programs based on potential determinants of per capita drug expenditure.
    Roy S; Madhavan SS
    Res Social Adm Pharm; 2009 Mar; 5(1):51-62. PubMed ID: 19285289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization, price, and spending trends for antidepressants in the US Medicaid Program.
    Chen Y; Kelton CM; Jing Y; Guo JJ; Li X; Patel NC
    Res Social Adm Pharm; 2008 Sep; 4(3):244-57. PubMed ID: 18794035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent trends in drug prescribing rates and costs in New Zealand.
    Malcolm LA; Mehl A
    N Z Med J; 1988 May; 101(845):233-6. PubMed ID: 3368132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly.
    Liu SZ; Romeis JC
    Med Care; 2003 Dec; 41(12):1331-42. PubMed ID: 14668666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seniors' prescription drug cost inflation and cost containment: evidence from British Columbia.
    Morgan SG; Agnew JD; Barer ML
    Health Policy; 2004 Jun; 68(3):299-307. PubMed ID: 15113641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in Medicaid prescription volume and use in the wake of Medicare Part D implementation.
    Bruen BK; Miller LM
    Health Aff (Millwood); 2008; 27(1):196-202. PubMed ID: 18180495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans.
    Patel UD; Davis MM
    J Am Soc Nephrol; 2006 Sep; 17(9):2546-53. PubMed ID: 16855016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in Medicaid physician fees, 2003-2008.
    Zuckerman S; Williams AF; Stockley KE
    Health Aff (Millwood); 2009; 28(3):w510-9. PubMed ID: 19401290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription drugs and the changing concentration of health care expenditures.
    Zuvekas SH; Cohen JW
    Health Aff (Millwood); 2007; 26(1):249-57. PubMed ID: 17211035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.